2011
Karnani M. M., Apergis-Schoute J., Adamantidis A., Jensen L. T., de Lecea L., Fugger L., Burdakov D. (2011). Activation of central orexin/hypocretin neurons by dietary amino acids, Neuron, 72(4), 616-29. Find out more.
Kauwe J. S., Cruchaga C., Karch C. M., Sadler B., Lee M., Mayo K., Latu W., Su'a M., Fagan A. M., Holtzman D. M., Morris J. C., Breitner J., Alzheimer's Disease Neuroimaging Initiative, Goate A. M. (2011). Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease, PLoS One, 6(2), e15918. Find out more.
Landau A. M., Chakravarty M., Clark C. M., Zis A. P., Doudet D. J. (2011). Electroconvulsive therapy alters dopamine signaling in the striatum of non-human primates, Neuropsychopharmacology, 36(2), 511-8. Find out more.
Lederbogen F., Kirsch P., Haddad L., Streit F., Tost H., Schuch P., Wust S., Pruessner J., Rietschel M., Deuschle M., Meyer-Lindenberg A. (2011). City living and urban upbringing affect neural social stress processing in humans, Nature, 474(7352), 498-501. Find out more.
Leduc V., Domenger D., De Beaumont L., Lalonde D., Belanger-Jasmin S., Poirier J. (2011). Function and comorbidities of apolipoprotein e in Alzheimer's disease, Int J Alzheimers Dis, 2011, 974361. Find out more.
Leduc V., Legault V., Dea D., Poirier J. (2011). Normalization of gene expression using SYBR green qPCR: A case for paraoxonase 1 and 2 in Alzheimer's disease brains, J Neurosci Methods, 200(1), 14-19. Find out more.
Lerch J.P., Yiu A.P., Martinez-Canabal A., Pekar T., Bohbot V., Frankland P.W., Henkelman R.M., Josselyn S.A., Sled J.G. (2011). Maze training in mice induces MRI-detectable brain shape changes specific to the type of learning, Neuroimage, 54(3), 2086-2095. Find out more.
Lupien S.J., Parent S., Evans A.C., Tremblay R.E., Zelazo P.D., Corbo V., Pruessner J., Seguin J.R. (2011). Larger amygdala but no change in hippocampal volume in 10-year-old children exposed to maternal depressive symptomatology since birth, Proc Natl Acad Sci U S A, 108(34), 14324-14329. Find out more.
Maillet D., Rajah M. (2011). Age-related changes in the three-way correlation between anterior hippocampus volume, whole-brain patterns of encoding activity and subsequent context retrieval, Brain Res, 1420, 68-79. Find out more.
Marca R.L., Waldvogel P., Thorn H., Tripod M., Wirtz P.H., Pruessner J., Ehlert U. (2011). Association between Cold Face Test-induced vagal inhibition and cortisol response to acute stress, Psychophysiology, 48(3), 420-429. Find out more.
Mareckova K., Weinbrand Z., Chakravarty M., Lawrence C., Aleong R., Leonard G., Perron M., Pike G. B., Richer L., Veillette S., Pausova Z., Paus T. (2011). Testosterone-mediated sex differences in the face shape during adolescence: subjective impressions and objective features, Horm Behav, 60(5), 681-90. Find out more.
Massoud F., Desmarais J.E., Gauthier S. (2011). Switching cholinesterase inhibitors in older adults with dementia, Int Psychogeriatr, 23(3), 372-378. Find out more.
Matousek R.H., Pruessner J., Dobkin P.L. (2011). Changes in the cortisol awakening response (CAR) following participation in mindfulness-based stress reduction in women who completed treatment for breast cancer, Complement Ther Clin Pract, 17(2), 65-70. Find out more.
Mayeux R., Reitz C., Brickman A.M., Haan M.N., Manly J.J., Glymour M.M., Weiss C.C., Yaffe K., Middleton L., Hendrie H.C., Warren L.H., Hayden K.M., Welsh-Bohmer K.A., Breitner J., Morris J.C. (2011). Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1, Alzheimers Dement, 7(1), 15-34. Find out more.
McEvoy L. K., Holland D., Hagler D. J., Fennema-Notestine C., Brewer J. B., Dale A. M., Breitner J., Alzheimer's Disease Neuroimaging Initiative (2011). Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis, Radiology, 259(3), 834-43. Find out more.
Nicolakakis N., Aboulkassim T., Aliaga A., Tong X.K., Rosa-Neto P., Hamel E. (2011). Intact memory in TGF-beta1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone, J Cereb Blood Flow Metab, 31(1), 200-211. Find out more.
Norton M. C., Smith K. R., Ostbye T., Tschanz J. T., Schwartz S., Corcoran C., Breitner J., Steffens D. C., Skoog I., Rabins P. V., Welsh-Bohmer K. A., Cache County Investigators (2011). Early parental death and remarriage of widowed parents as risk factors for Alzheimer disease: the Cache County study, Am J Geriatr Psychiatry, 19(9), 814-24. Find out more.
Oishi K., Huang H., Yoshioka T., Ying S. H., Zee D. S., Zilles K., Amunts K., Woods R., Toga A. W., Pike G. B., Rosa-Neto P., Evans A. C., van Zijl P. C., Mazziotta J. C., Mori S. (2011). Superficially located white matter structures commonly seen in the human and the macaque brain with diffusion tensor imaging, Brain Connect, 1(1), 37-47. Find out more.
Pasic M.D., Diamandis E.P., McLaurin J., Holtzman D.M., Schmitt-Ulms G., Quirion R. (2011). Alzheimer Disease: Advances in Pathogenesis, Diagnosis, and Therapy, Clin Chem. Find out more.
Poirier J., Gauthier S. (2011). La Maladie D’Alzheimer: Le Guide , .